Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hala Al Asadi"'
Autor:
Jessica Limberg, Caitlin E. Egan, Katherine D. Gray, Mandeep Singh, Zachary Loewenstein, Yanping Yang, Maria Cristina Riascos, Hala Al Asadi, Parima Safe, Steve El Eshaky, Heng Liang, Timothy M. Ullmann, Weibin Wang, Wei Li, Tuo Zhang, Jenny Xiang, Dessislava Stefanova, Moonsoo M. Jin, Rasa Zarnegar, Thomas J. Fahey, Irene M. Min
Publikováno v:
Molecular Cancer Research. 21:397-410
A subset of thyroid cancers, recurrent differentiated thyroid cancers and anaplastic thyroid cancer (ATC), are difficult to treat by thyroidectomy and systemic therapy. A common mutation in thyroid cancer, BRAFV600E, has targetable treatment options;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a99f0c4789c8e6e6e83d0df7d71f8d66
https://doi.org/10.1158/1541-7786.mcr-21-0832
https://doi.org/10.1158/1541-7786.mcr-21-0832
Autor:
Irene M. Min, Thomas J. Fahey, Rasa Zarnegar, Moonsoo M. Jin, Dessislava Stefanova, Jenny Xiang, Tuo Zhang, Wei Li, Weibin Wang, Timothy M. Ullmann, Heng Liang, Steve El Eshaky, Parima Safe, Hala Al Asadi, Maria Cristina Riascos, Yanping Yang, Zachary Loewenstein, Mandeep Singh, Katherine D. Gray, Caitlin E. Egan, Jessica Limberg
S1. BRAFV600E mutation identified in thyroid cancer cell lines analyzed by RNA-seq.S2. STR analysis in thyroid cancer cell lines used in this study.S3. Gene expression of thyroid-specific genes in thyroid cancer cell lines analyzed by RNA-seq.S4. Dos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08c03a3039ae476a972e72bf0da1627b
https://doi.org/10.1158/1541-7786.22725440.v1
https://doi.org/10.1158/1541-7786.22725440.v1
Autor:
Irene M. Min, Thomas J. Fahey, Rasa Zarnegar, Moonsoo M. Jin, Dessislava Stefanova, Jenny Xiang, Tuo Zhang, Wei Li, Weibin Wang, Timothy M. Ullmann, Heng Liang, Steve El Eshaky, Parima Safe, Hala Al Asadi, Maria Cristina Riascos, Yanping Yang, Zachary Loewenstein, Mandeep Singh, Katherine D. Gray, Caitlin E. Egan, Jessica Limberg
Supplementary Table 1. Gene expression changes in 8505C after vemurafenib treatment.Supplementary Table 2. Gene expression changes in WRO after vemurafenib treatment.Supplementary Table 3. Gene expression changes in 8505C -Vem-Res 1 relative to paren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13b6b2bf942c9fc01ea3a25256b6cd0c
https://doi.org/10.1158/1541-7786.22725437
https://doi.org/10.1158/1541-7786.22725437
Autor:
Irene M. Min, Thomas J. Fahey, Rasa Zarnegar, Moonsoo M. Jin, Dessislava Stefanova, Jenny Xiang, Tuo Zhang, Wei Li, Weibin Wang, Timothy M. Ullmann, Heng Liang, Steve El Eshaky, Parima Safe, Hala Al Asadi, Maria Cristina Riascos, Yanping Yang, Zachary Loewenstein, Mandeep Singh, Katherine D. Gray, Caitlin E. Egan, Jessica Limberg
A subset of thyroid cancers, recurrent differentiated thyroid cancers and anaplastic thyroid cancer (ATC), are difficult to treat by thyroidectomy and systemic therapy. A common mutation in thyroid cancer, BRAFV600E, has targetable treatment options;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7db8dedaf7a0db58a32cdf502c9936a
https://doi.org/10.1158/1541-7786.c.6545598.v1
https://doi.org/10.1158/1541-7786.c.6545598.v1